Company History

November 2026 - Fundraising campaign successfully finished

DendroPharm has successfully raised more than €600,000 through the investment platform FunderNation. The funding was secured through investments from Business Angels and pari passu loans, demonstrating strong investor confidence in DendroPharm’s innovative technology and growth potential. The funds will support the further development of our nanotechnology-based drug delivery platform, strengthen our R&D activities and accelerate our product pipeline. We would like to thank all investors for their trust and support in bringing our innovations closer to market.

September 2026 - Extended Manufacturing Authorization Granted under GMP

DendroPharm receives the extended manufacturing authorization, confirming its status as a GMP-compliant manufacturer of medicinal products. This brings the final manufacturing of our ointment for cats, based on our patented drug delivery platform technology using CMS nanoparticles, a significant step closer.

October 2025 - FOCUS Innovation Award 2026 for the Second Consecutive Year

Ausgezeichnet mit dem FOCUS-Innovationspreis 2025

DendroPharm has been awarded the FOCUS Innovation Award 2026, marking the second consecutive year the company has received this prestigious recognition. The award, presented by the German news magazine FOCUS, honors groundbreaking innovations with strong market potential and the ability to create new opportunities for growth. A distinguished jury of experts from business, science, politics and the start-up ecosystem evaluates innovative products and services based on their relevance to consumers and their market prospects. The award highlights companies whose innovations have the potential to make a meaningful impact on the future. This repeated recognition underlines DendroPharm’s commitment to advancing innovative nanotechnology-based drug delivery solutions.

January 2023 - Veterinary Manufacturing License

DendroPharm obtains the manufacturing license for analytics and release of veterinary medical products

January 2022 - GMP Approval from LaGeSo

Certification according to GMP by the state authority LaGeSo

January 2019 - New Premises for DendroPharm

DendroPharm moves to a new location in Lankwitzer Straße with 800 m² of cleanroom, laboratory, storage and production facilities.

October 2017 - DendroPharm Joins NetPhaSol Network

DendroPharm becomes a member of the “Network for Pharma Solutions” NetPhaSol. This cooperation network for drug development serves as a platform for research, development and marketing of new products, processes and services. The primary focus is on first value chain stages of drug development – however, further development stages are not excluded. DendroPharm is now broadening NetPhaSol´s profile with its expertise in CMS Nanocarriers and dermal drug delivery.

December 2016 - DendroPharm Wins Innovation Award

DendroPharm wins the Innovation Award Berlin-Brandenburg.
The Innovation Award Berlin-Brandenburg is one of the most prestigious awards for novel products and is awarded annually. 120 innovative products by large, small and medium enterprises have entered the competition in 2016. Of those, 5 innovations have won awards. DendroPharm GmbH develops nanocarriers which enable a highly efficient transdermal drug transfer for both lipophilic and hydrophilic compounds. DendroSol® nanocarriers are non-toxic, biodegradable and do not irritate the skin. This results in significantly reduced side effects. The technology has been developed together with Prof. Rainer Haag from the Freie Universität Berlin. It enables patients to switch their daily medication from oral to transdermal and thus prevent gastrointestinal side effects.

November 2016 - Dr. Moré Presents on Polymer-Based Nanomaterials

Presentation: “Polymerbasierte Nanomaterialien – Anwendungsmöglichkeiten und regulatorische Hürden” (Polymer-based nanomaterials – applications and regulatory hurdles), Dr. Sam Dylan Moré, DendroPharm GmbH.

April 2016 - Partnership with ViscoTec on GMP Filling

DendroPharm becomes reference client of ViscoTec’s GMP grade filling technology for highly viscous semisolid drugs | pdf
ViscoTec is a leading German manufacturer of high precision dosing pump equipment. This technology will enable DendroPharm to offer its clients GMP grade investigational products for clinical trials of highly potent drugs and semi-solids from 2017 onwards.

September 2015 - DendroPharm Achieves ISO 9001:2008 Certification

DendroPharm’s quality management system successfully passed the certification by TÜV-SÜD according to the norm ISO 9001:2008. The scope is as follows: Research and development of nanomaterials and nanocarriers as pharmaceutical excipients, as well as of galenic products; production and purification of nanomaterials and nanocarriers for research purposes; production of nanomaterials and nanocarriers for veterinary products.

December 2014 - DendroPharm Qualifies for BAFA Subsidy

DendroPharm qualifies for inclusion in the BAFA program for a 20% subsidy for direct private investments of €10,000 or more. If interested, please get in touch with the management.

September 29, 2014 - DendroPharm Finalist for Technology Transfer Award 2014

DendroPharm finalist for the “technology transfer award 2014 of the Berliner Sparkasse”

April 14, 2014 - DendroPharm Takes Second Place in Business Plan Competition

DendroPharm achieved second place in the “Business Plan Competition Berlin-Brandenburg” (Businessplan-Wettbewerb Berlin-Brandenburg)

December 11, 2013 - DendroPharm Licenses Two Drug Delivery Patents

DendroPharm licenses two patents on controlled drug delivery from Freie Universität Berlin.

October 28, 2013 - DendroPharm Experts Contribute to FU Berlin Program

Dr. Henrik Luessen and Dr. Sam Dylan Moré support the “Entrepreneurship Lecture Program” of the Freie Universität Berlin. Dr. Henrik Luessen has been invited to give the starting lecture.

September 13, 2013 - DendroPharm Raises €1.2M in First Financing Round

DendroPharm GmbH raised €1.2 million in the first financing round by successfully qualifying for the “ProFit” start-up program of IBB – Investitionsbank Berlin and the ERDF fund of the European Union.

February 14, 2013 - Science4Life 2013: DendroPharm in Top 20

DendroPharm was among the 20 best teams of the “Science4Life” concept phase in 2013. | More …

August 14, 2012 - DendroPharm Reaches Second Round in BMBF GoBio

The team of DendroPharm GmbH reached the second evaluation round of the “BMBF GoBio” competition.